Learn More
Medchemexpress LLC YK-3-237 | 1215281-19-8 | 99.5% | 372.18 | 100 MG

Supplier: Medchemexpress LLC HY19634100MG
YK-3-237 is a SIRT1 activator that targets mutant p53. It inhibits the proliferation of triple-negative breast cancer cells.
- SIRT1 activator
- Targets mutant p53
- Inhibits the proliferation of triple-negative breast cancer cells
- Exhibits anti-proliferative activities towards most breast cancer cell lines at submicromolar concentrations
- Preferentially inhibits the proliferation of breast cancer cell lines carrying mtp53
- Deacetylates mtp53 in TNBC cell lines
- Potent activator of Sirt1, on the activation of renal interstitial fibroblasts using NRK-49F cells
- Significantly reduces expression of α-SMA and fibronectin in a dose-dependent manner in NRK-49F cells
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.